atenolol has been researched along with Diabetes Mellitus, Type 1 in 10 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nine patients with Type I diabetes mellitus, diastolic blood pressure of 90 to 100 mmHg and persistent microalbuminuria of greater than or equal to 30 micrograms/min were treated with 50 to 100 mg atenolol daily for 3 years in an uncontrolled pilot study to assess the effect of long-term reduction of blood pressure on microalbuminuria." | 7.68 | Treatment with atenolol prevents progression of microalbuminuria in type I diabetic patients. ( Davies, JA; Stickland, M; Tindall, H; Urquhart, S, 1991) |
| "The aim of the study was to evaluate the efficacy of enalapril and atenolol in decreasing the severity of proteinuria in hypertensive patients suffering from insulin-dependent diabetes mellitus." | 5.07 | Effects of atenolol and enalapril on kidney function in hypertensive diabetic patients. ( Andriani, A; Bonfantino, MV; De Cesaris, R; Filitti, V; Ranieri, G, 1993) |
| "Nine patients with Type I diabetes mellitus, diastolic blood pressure of 90 to 100 mmHg and persistent microalbuminuria of greater than or equal to 30 micrograms/min were treated with 50 to 100 mg atenolol daily for 3 years in an uncontrolled pilot study to assess the effect of long-term reduction of blood pressure on microalbuminuria." | 3.68 | Treatment with atenolol prevents progression of microalbuminuria in type I diabetic patients. ( Davies, JA; Stickland, M; Tindall, H; Urquhart, S, 1991) |
| "We studied 49 patients with type 1 diabetes (age 50." | 2.73 | Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. ( Crea, F; Ghirlanda, G; Infusino, F; Lanza, GA; Manto, A; Musella, T; Navarese, EP; Pitocco, D; Sestito, A; Sgueglia, GA, 2007) |
| "The progression of diabetic nephropathy can be positively influenced by maintaining a low blood pressure level." | 2.67 | Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study. ( Berden, JH; de Nobel, E; Elving, LD; van Lier, HJ; Wetzels, JF, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SP | 1 |
| Harris, ND | 1 |
| Robinson, RT | 1 |
| Davies, C | 1 |
| Ireland, R | 1 |
| Macdonald, IA | 1 |
| Heller, SR | 1 |
| Baumgart, P | 1 |
| Lanza, GA | 1 |
| Pitocco, D | 1 |
| Navarese, EP | 1 |
| Sestito, A | 1 |
| Sgueglia, GA | 1 |
| Manto, A | 1 |
| Infusino, F | 1 |
| Musella, T | 1 |
| Ghirlanda, G | 1 |
| Crea, F | 1 |
| De Cesaris, R | 1 |
| Ranieri, G | 1 |
| Filitti, V | 1 |
| Andriani, A | 1 |
| Bonfantino, MV | 1 |
| Hardy, KJ | 1 |
| Elving, LD | 1 |
| Wetzels, JF | 1 |
| van Lier, HJ | 1 |
| de Nobel, E | 1 |
| Berden, JH | 1 |
| Levinson, PD | 1 |
| Benn, JJ | 1 |
| Brown, PM | 1 |
| Beckwith, LJ | 1 |
| Farebrother, M | 1 |
| Sönksen, PH | 1 |
| Tindall, H | 2 |
| Urquhart, S | 1 |
| Stickland, M | 1 |
| Davies, JA | 2 |
| Hopper, AH | 1 |
1 review available for atenolol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Beta-blockers, diabetes, and hypoglycemia: risky business?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aten | 2001 |
3 trials available for atenolol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atenolol; Autonomic Nervous System Diseases; C-Re | 2007 |
Effects of atenolol and enalapril on kidney function in hypertensive diabetic patients.
Topics: Adult; Atenolol; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 1; Diabetic Neph | 1993 |
Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
Topics: Adult; Albuminuria; Atenolol; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephrop | 1994 |
6 other studies available for atenolol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Effect of atenolol on QTc interval lengthening during hypoglycaemia in type 1 diabetes.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Diabetes Mellitus, Type 1; Electrocardiograph | 2005 |
[Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2006 |
Antihypertensives retarding progression of diabetic nephropathy.
Topics: Atenolol; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans | 1995 |
Glucose turnover in type I diabetic subjects during exercise. Effect of selective and nonselective beta-blockade and insulin withdrawal.
Topics: Adult; Atenolol; Betaxolol; Blood Glucose; Diabetes Mellitus, Type 1; Exercise; Glucose; Glycated He | 1992 |
Treatment with atenolol prevents progression of microalbuminuria in type I diabetic patients.
Topics: Adult; Albuminuria; Atenolol; Blood Pressure; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephro | 1991 |
The course of incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Atenolol; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Middle Aged | 1986 |